دورية أكاديمية
أعرض في EDS

Disparities in Access to Radiotherapy Among Hispanic/Latinx Populations in the United States: How Far Have We Left to Go?

التفاصيل البيبلوغرافية
العنوان: Disparities in Access to Radiotherapy Among Hispanic/Latinx Populations in the United States: How Far Have We Left to Go?
المؤلفون: Verdini NP; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Santos PMG; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY., Vicioso-Mora YM; Department of Radiation Oncology, Duke University, Durham, NC., Rivera A; Department of Radiation Oncology, University of Miami, Miami, FL., Perez CA; Department of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, TN., McClelland S; Department of Radiation Oncology and Neurological Surgery, University Hospitals Seidman Cancer Center, Case Western Reserve, Cleveland, OH.
المصدر: American journal of clinical oncology [Am J Clin Oncol] 2024 Jan 01; Vol. 47 (1), pp. 40-47. Date of Electronic Publication: 2023 Oct 26.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8207754 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-453X (Electronic) Linking ISSN: 02773732 NLM ISO Abbreviation: Am J Clin Oncol Subsets: MEDLINE
أسماء مطبوعة: Publication: Hagerstown, MD : Lippincott Williams & Wilkins
Original Publication: New York, N.Y. : Masson Pub. USA, c1982-
مواضيع طبية MeSH: Healthcare Disparities* , Radiation Oncology*, Humans ; Hispanic or Latino ; United States ; Health Services Accessibility
مستخلص: Objectives: The Hispanic/Latinx population has consistently faced disparities in oncology access and outcomes with cancer being the leading cause of death in this population. We evaluate recent research in radiation therapy disparities among the Hispanic/Latinx population in the United States since our seminal analysis from 2017.
Methods: A PubMed literature search was conducted for articles published from January 2017 through March 2023. Four term combinations were utilized, including: (1) "Hispanic" and "Radiotherapy" and "Disparities", (2) "Latino" and "Radiotherapy" and "Hispanic", (3) "Hispanic" and "Radiation" and "Disparities", and (4) "Latino" and "Radiation" and "Disparities." Included studies were those taking place in the United States, examined radiation oncology care, and examined health disparities.
Results: Fifty-eight of 245 articles returned met inclusion criteria and spanned 6 disparity-types: (1) Stage at Presentation, (2) Time to Treatment Initiation & Completion, (3) Receipt of Treatment and Guideline-Concordant Care, (4) Geography, (5) Clinical Trial Access and (6) Insurance Barriers and Treatment Center Type. The most common disparity was receipt of treatment and guideline-concordant care (n=39 studies), demonstrating that the Hispanic/Latinx population was less likely to receive guideline-concordant treatment or treatment at all. In additon, studies identified disparities in time to treatment and completion (n=12), geography (n=5), clinical trial access (n=3), and insurance and treatment center access (n=5).
Conclusions: Disparities in radiotherapy access remain prominent for the Hispanic/Latinx population through a multitude of barriers, despite increasing interest in disparities research. Continued health care disparities research with tangible interventions are needed in radiation oncology to properly understand and address this problem.
Competing Interests: The authors declare no conflicts of interest.
(Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.)
References: American Cancer Society Cancer Facts & Figures for Hispanics/Latinos 2018-2020.
Pompa IR, Ghosh A, Bhat S, et al. US Cancer Mortality Trends Among Hispanic Populations From 1999 to 2020. JAMA Oncol. 2023;9:1090.
Krogstad J, Passel Jeffrey, Noe-Bustamante Luis Key facts about U.S. Latinos for National Hispanic Heritage Month. Pew Research Center. 2023. https://www.pewresearch.org/short-reads/2022/09/23/key-facts-about-u-s-latinos-for-national-hispanic-heritage-month/.
Dayan GS, Bahig H, Johnson-Obaseki S, et al. Oncologic significance of therapeutic delays in patients with oral cavity cancer. JAMA Otolaryngol Head Neck Surg. 2023:e231936. doi:10.1001/jamaoto.2023.1936. (PMID: 10.1001/jamaoto.2023.1936)
Hall IJ, Rim SH, Dasari S. Preventive care use among Hispanic adults with limited comfort speaking English: an analysis of the Medical Expenditure Panel Survey data. Prev Med. 2022;159:107042.
Terceira Berdahl PD Prevelance of Paid Sick Leave Among Wage Earners . 2021. https://meps.ahrq.gov/data_files/publications/rf47/rf47.pdf.
Peipins LA, Soman A, Berkowitz Z, et al. The lack of paid sick leave as a barrier to cancer screening and medical care-seeking: results from the National Health Interview Survey. BMC Public Health. 2012;12:520.
OoHP HHS. Health Insurance Coverage and Access to Care Among Latinos: Recent Trends and Key Challenges 2021. https://aspe.hhs.gov/sites/default/files/documents/68c78e2fb15209dd191cf9b0b1380fb8/ASPE_Latino_Health_Coverage_IB.pdf.
Martinez-Donate AP, Verdecias N, Zhang X, et al. Health Profile and Health Care Access of Mexican Migration Flows Traversing the Northern Border of Mexico. Med Care. 2020;58:474–482.
McClelland S 3rd, Perez CA. The pervasive crisis of diminishing radiation therapy access for vulnerable populations in the United States-part 3: Hispanic-American patients. Adv Radiat Oncol. 2018;3:93–99.
Jaiswal K, Hull M, Furniss AL, et al. Delays in diagnosis and treatment of breast cancer: a safety-net population profile. J Natl Compr Canc Netw. 2018;16:1451–1457.
Sukniam K, Kasbi AA, Ashary MA, et al. Disparities in time to treatment for breast cancer. Anticancer Res. 2022;42:5813–5818.
Verdone CG, Bayron JA, Chang C, et al. A tool to predict disparities in the timeliness of surgical treatment for breast cancer patients in the USA. Breast Cancer Res Treat. 2022;191:513–522.
Ramey SJ, Asher D, Kwon D, et al. Delays in definitive cervical cancer treatment: an analysis of disparities and overall survival impact. Gynecol Oncol. 2018;149:53–62.
Ramey SJ, Rich BJ, Kwon D, et al. Demographic disparities in delay of definitive chemoradiation for anal squamous cell carcinoma: a nationwide analysis. J Gastrointest Oncol. 2018;9:1109–1126.
Hutten RJ, Weil CR, Gaffney DK, et al. Racial and ethnic health disparities in delay to initiation of intensity-modulated radiotherapy. JCO Oncol Pract. 2022;18:e1694–e1703.
Ostrom QT, Krebs HL, Patil N, et al. Racial/ethnic disparities in treatment pattern and time to treatment for adults with glioblastoma in the US. J Neurooncol. 2021;152:603–615.
Krimphove MJ, Fletcher SA, Cole AP, et al. Quality of care in the treatment of localized intermediate and high risk prostate cancer at minority serving hospitals. J Urol. 2019;201:735–741.
Lamm R, Woodward SG, Varshney K, et al. A comparison of timely completion of hypofractionated and traditional adjuvant radiation therapy in early-stage breast cancer: evidence of impact on reducing racial and socioeconomic disparities. Surgery. 2022;172:31–40.
Mantz CA, Thaker NG, Deville C Jr, et al. A medicare claims analysis of racial and ethnic disparities in the access to radiation therapy services. J Racial Ethn Health Disparities. 2023;10:501–508.
Parekh A, Fu W, Hu C, et al. Impact of race, ethnicity, and socioeconomic factors on receipt of radiation after breast conservation surgery: analysis of the national cancer database. Breast Cancer Res Treat. 2018;172:201–208.
Bagley AF, Anscher MS, Choi S, et al. Association of sociodemographic and health-related factors with receipt of nondefinitive therapy among younger men with high-risk prostate cancer. JAMA Netw Open. 2020;3:e201255.
Lu VM, Shah AH, Eichberg DG, et al. Geographic disparities in access to glioblastoma treatment based on Hispanic ethnicity in the United States: Insights from a national database. J Neurooncol. 2020;147:711–720.
Graboyes EM, Ellis MA, Li H, et al. Racial and ethnic disparities in travel for head and neck cancer treatment and the impact of travel distance on survival. Cancer. 2018;124:3181–3191.
Patel MA, Shah JL, Abrahamse PH, et al. A population-based study of invitation to and participation in clinical trials among women with early-stage breast cancer. Breast Cancer Res Treat. 2020;184:507–518.
Javier-DesLoges J, Nelson TJ, Murphy JD, et al. Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials. Cancer. 2022;128:770–777.
Ladbury C, Liu J, Novak J, et al. Age, racial, and ethnic disparities in reported clinical studies involving brachytherapy. Brachytherapy. 2022;21:33–42.
Stenzel AE, Buas MF, Moysich KB. Survival disparities among racial/ethnic groups of women with ovarian cancer: An update on data from the Surveillance, Epidemiology and End Results (SEER) registry. Cancer Epidemiol. 2019;62:101580.
Du XL, Song L. Racial disparities in treatments and mortality among a large population-based cohort of older men and women with colorectal cancer. Cancer Treat Res Commun. 2022;32:100619.
Perlow HK, Ramey SJ, Silver B, et al. Assessment of oropharyngeal and laryngeal cancer treatment delay in a private and safety net hospital system. Otolaryngol Head Neck Surg. 2018;159:484–493.
Patel AM, Ali O, Kainthla R, et al. Primary central nervous system lymphoma: a real-world comparison of therapy access and outcomes by hospital setting. Neurooncol Pract. 2022;9:183–192.
Nnorom SO, Baig H, Akinyemi OA, et al. Persistence of disparity in thyroid cancer survival after adjustments for socioeconomic status and access. Am Surg. 2022;88:1484–1489.
Jacobs AJ, Lindholm EB, Levy CF, et al. Racial and ethnic disparities in treatment and survival of pediatric sarcoma. J Surg Res. 2017;219:43–49.
Moore JX, Andrzejak SE, Jones S, et al. Exploring the intersectionality of race/ethnicity with rurality on breast cancer outcomes: SEER analysis, 2000-2016. Breast Cancer Res Treat. 2023;197:633–645.
Swami N, Baez YA, Franco I, et al. Localized prostate cancer disparities in risk group at presentation and access to treatment for Hispanic men. Prostate Cancer Prostatic Dis. 2023;26:309–316.
McDermott JD, Eguchi M, Morgan R, et al. Elderly Black non-Hispanic patients with head and neck squamous cell cancer have the worst survival outcomes. J Natl Compr Canc Netw. 2020;19:57–67.
Beaulieu-Jones BR, Shewmaker G, Fefferman A, et al. Mitigating disparities in breast cancer treatment at an academic safety-net hospital. Breast Cancer Res Treat. 2023;198:597–606.
Roy M, Finch L, Kwon D, et al. Factors contributing to delays in initiation of front-line cervical cancer therapy: disparities in a diverse south Florida population. Int J Gynecol Cancer. 2022;32:1387–1394.
Lee DJ, Zhao Z, Huang LC, et al. Racial variation in receipt of quality radiation therapy for prostate cancer. Cancer Causes Control. 2018;29:895–899.
des Bordes JKA, Lopez DS, Swartz MD, et al. Sociodemographic disparities in cure-intended treatment in localized prostate cancer. J Racial Ethn Health Disparities. 2018;5:104–110.
Chau B, Ituarte PH, Shinde A, et al. Disparate outcomes in nonsmall cell lung cancer by immigration status. Cancer Med. 2021;10:2660–2667.
Roche AM, Fedewa SA, Shi LL, et al. Treatment and survival vary by race/ethnicity in patients with anaplastic thyroid cancer. Cancer. 2018;124:1780–1790.
Baig MZ, Filkins A, Khan M, et al. Survival benefits and disparities in adjuvant radiation therapy for patients with pancreatic cancer. JOP. 2021;22:36–41.
Lee DY, Teng A, Pedersen RC, et al. Racial and socioeconomic treatment disparities in adolescents and young adults with stage II-III rectal cancer. Ann Surg Oncol. 2017;24:311–318.
Luo LY, Aviki EM, Lee A, et al. Socioeconomic inequality and omission of adjuvant radiation therapy in high-risk, early-stage endometrial cancer. Gynecol Oncol. 2021;161:463–469.
Kaspers M, Llamocca E, Quick A, et al. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment. Am J Obstet Gynecol. 2020;223:398 e1–398 e18.
Gray PJ, Lin CC, Cooperberg MR, et al. Temporal trends and the impact of race, insurance, and socioeconomic status in the management of localized prostate cancer. Eur Urol. 2017;71:729–737.
Vassantachart A, Marietta M, Mehta S, et al. Racial disparities and standard treatment in locally advanced rectal cancer: a National Cancer Database study. J Gastrointest Oncol. 2022;13:2922–2937.
Perlow HK, Ramey SJ, Cassidy V, et al. Disparities in adherence to head and neck cancer follow-up guidelines. Laryngoscope. 2019;129:2303–2308.
Anteby R, Blaszkowsky LS, Hong TS, et al. Disparities in receipt of adjuvant therapy after upfront surgical resection for pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2023;30:2473–2481.
Blom EF, Ten Haaf K, Arenberg DA, et al. Disparities in receiving guideline-concordant treatment for lung cancer in the United States. Ann Am Thorac Soc. 2020;17:186–194.
Seldon C, Shrivastava G, Al-Awady A, et al. Variation in management of extremity soft-tissue sarcoma in younger vs older adults. JAMA Netw Open. 2021;4:e2120951.
Dressler EV, Liu M, Garcia CR, et al. Patterns and disparities of care in glioblastoma. Neurooncol Pract. 2019;6:37–46.
Uppal S, Chapman C, Spencer RJ, et al. Association of hospital volume with racial and ethnic disparities in locally advanced cervical cancer treatment. Obstet Gynecol. 2017;129:295–304.
Greer MD, Amiri S, Denney JT, et al. Disparities in access to radiation therapy facilities among American Indians/Alaska Natives and Hispanics in Washington State. Int J Radiat Oncol Biol Phys. 2022;112:285–293.
LaVigne AW, DeWeese TL, Wright JL, et al. Radiotherapy deserts: the impact of race, poverty, and the rural-urban continuum on density of providers and the use of radiation therapy in the US. Int J Radiat Oncol Biol Phys. 2023;116:17–27.
Services USDoHaH. Profile: Hispanic/Latino Americans. https://minorityhealth.hhs.gov/omh/browse.aspx?lvl=3&lvlid=64#:~:text=Among%20full%2Dtime%20year%2Dround,U.S.%20Bureau%20of%20Labor%20Statistics.
DeVoe JE, Tillotson CJ, Marino M, et al. Trends in type of health insurance coverage for US Children and Their Parents, 1998-2011. Acad Pediatr. 2016;16:192–199.
Syed ST, Gerber BS, Sharp LK. Traveling towards disease: transportation barriers to health care access. J Community Health. 2013;38:976–993.
Onega T, Duell EJ, Shi X, et al. Race versus place of service in mortality among medicare beneficiaries with cancer. Cancer. 2010;116:2698–2706.
O’Connor JM, Sedghi T, Dhodapkar M, et al. factors associated with cancer disparities among low-, medium-, and high-income US counties. JAMA Netw Open. 2018;1:e183146.
Yoder AK, Dong E, Yu X, et al. Effect of quality of life on radiation adherence for patients with cervical cancer in an urban safety net health system. Int J Radiat Oncol Biol Phys. 2023;116:182–190.
Takeshita J, Wang S, Loren AW, et al. Association of racial/ethnic and gender concordance between patients and physicians with patient experience ratings. JAMA Netw Open. 2020;3:e2024583.
Shen MJ, Peterson EB, Costas-Muniz R, et al. The effects of race and racial concordance on patient-physician communication: a systematic review of the literature. J Racial Ethn Health Disparities. 2018;5:117–140.
McClelland S III, Huang CC, Griffith KA, et al. Composition of the current academic radiation oncology workforce in comprehensive cancer centers. JCO Oncol Pract. 2022;18:e740–e747.
Deville C Jr, Cruickshank I Jr, Chapman CH, et al. I Can’t Breathe: The Continued Disproportionate Exclusion of Black Physicians in the United States Radiation Oncology Workforce. Int J Radiat Oncol Biol Phys. 2020;108:856–863.
Duma N, Velazquez AI, Franco I, et al. Donde Estan? Latinx/Hispanic Representation in the Oncology Workforce: Present and Future. JCO Oncol Pract. 2022;18:388–395.
Mattes MD, Deville C Jr, Vega RBM, et al. Demographics of ASTRO Student Members and Potential Implications for Future U.S. Radiation Oncology Workforce Diversity. Adv Radiat Oncol. 2022;7:100834.
Nead KT, Linos E, Vapiwala N. Increasing diversity in radiation oncology: a call to action. Adv Radiat Oncol. 2019;4:226–228.
Colleges AoAM. Advancing Diversity, Equity, and Inclusion in Medical Education. September 8th, 2023. https://www.aamc.org/about-us/equity-diversity-inclusion/advancing-diversity-equity-and-inclusion-medical-education.
Seible DM, Kundu S, Azuara A, et al. the influence of patient-provider language concordance in cancer care: results of the hispanic outcomes by language approach (HOLA) randomized trial. Int J Radiat Oncol Biol Phys. 2021;111:856–864.
Ledesma Vicioso N, Lin D, Gomez DR, et al. Implementation strategies to increase clinical trial enrollment in a community-academic partnership and impact on hispanic representation: an interrupted time series analysis. JCO Oncol Pract. 2022;18:e780–e785.
تواريخ الأحداث: Date Created: 20231026 Date Completed: 20231228 Latest Revision: 20231228
رمز التحديث: 20231228
DOI: 10.1097/COC.0000000000001063
PMID: 37880834
قاعدة البيانات: MEDLINE
الوصف
تدمد:1537-453X
DOI:10.1097/COC.0000000000001063